API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206771
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216548
https://recalls-rappels.canada.ca/en/alert-recall/diclofenac-sodium-micronized-out-specification-affected-lot
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-launches-generic-joint-pain-drug-in-us-market/articleshow/96106366.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://www.moneycontrol.com/news/business/companies/alembic-pharma-gets-usfda-nod-for-generic-drug-2-9633031.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212506
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216275
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208021
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208198
https://www.expresspharma.in/aleor-dermaceuticals-gets-usfda-approval-for-diclofenac-sodium-topical-gel/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212351
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207714
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-27-2022-1651037135.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-22-2021-1640158210.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-1-2021-1638337020.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206655
https://www.perrigo.com/press-release/perrigo-announces-store-brand-equivalent-voltarenr-arthritis-pain-available-us-major
https://www.perrigo.com/press-release/perrigo-announces-store-brand-equivalent-voltarenr-arthritis-pain-available-us-major
https://www.pharmaexcipients.com/news/multiparticulate-formulations-diclofenac-sodium/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207714
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208098
https://www.prnewswire.com/news-releases/perrigo-announces-fda-approval-for-the-store-brand-equivalent-of-voltaren-arthritis-pain-301035806.html
https://www.raps.org/news-and-articles/news-articles/2020/2/rx-to-otc-switches-fda-signs-off-on-three-drugs
https://www.fda.gov/news-events/press-announcements/fda-approves-three-drugs-nonprescription-use-through-rx-otc-switch-process
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208786
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211253
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204306
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-3-2019-1554267295.pdf
https://www.raps.org/news-and-articles/news-articles/2019/1/asia-regulatory-roundup-tga-brings-6-guidance-doc?utm_source=MagnetMail&utm_medium=Email%20&utm_campaign=RF%20Today%20%7C%2022%20January
https://www.prnewswire.com/news-releases/perrigo-launches-its-ab-rated-generic-version-of-solaraze-gel-3-300755902.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209484
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209903
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210893
https://www.prnewswire.com/news-releases/lannett-announces-multiple-product-launches-300684483.html
https://www.thepharmaletter.com/in-brief/brief-ftc-imposes-conditions-on-amneal-acquisition-of-impax
https://www.ftc.gov/news-events/press-releases/2018/07/ftc-approves-final-order-imposing-conditions-merger-generic-drug
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-30-2018-1527659653.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206411
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208786
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206715
http://www.raps.org/Regulatory-Focus/News/2017/07/13/28078/FDA-Publishes-21-New-13-Revised-Draft-Generic-Drug-Guidances/?utm_source=Email&utm_medium=Informz&utm_campaign=Informz-Emails
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207238
https://www.pharmacompass.com/pdf/news/actavis-labs-ut-inc-gegeric-diclofenac-sodium-approved-in-us-1475663835.pdf
https://www.pharmacompass.com/pdf/news/amneal-pharms-generic-diclofenac-sodium-approved-in-us-1473506705.pdf
https://www.pharmacompass.com/pdf/news/par-forms-generic-diclofenac-potassium-approved-in-us-to-reduce-pain-and-inflammation-1462507646.pdf
https://www.pharmacompass.com/pdf/news/taros-generic-diclofenac-sodium-approved-in-us-for-osteoarthritis-pain-1462507806.pdf
http://www.prnewswire.com/news-releases/endo-provides-statement-regarding-expected-fda-approval-of-generic-voltaren-gel-product-300238782.html